CNS Biomarkers: Drug Discovery, Research and Development

The term Biomarker can be characterized as a quantifiable marker of some organic state or condition. A biomarker can likewise be known as an organic biomarker. Meetings revolve around the advancement of CNS biomarkers for pharmaceuticals and diagnostics from Cerebrospinal fluid and Blood, and in addition imaging approaches. Logical information, updates and contextual analyses in neurological and neurodegenerative illnesses will be introduced on sickness regions, for example, Alzheimer's and Parkinson's.

  • Cerebrospinal fluid biomarkers
  • Neuroimaging enrichment biomarkers for CNS diseases
  • Biomarker Challenges in Rare Diseases
  • Technology case studies for CNS
  • CNS drug development using biomarkers

Advances in multimodality fusion imaging technologies promise to accelerate the understanding of the systems biology of disease and help in the development of new therapeutics. The use of molecular imaging biomarkers has been proven to shorten cycle times for central nervous system (CNS) drug development and thereby increase the efficiency and return on investment from research. Imaging biomarkers can be utilized to help choose the molecules, doses, and patients well on the way to test remedial speculations by ceasing those that have minimal possibility of achievement and accelerating those with potential to achieve beneficial clinical outcomes. CNS imaging biomarkers have the potential to drive new medical care practices for patients in the latent phases of progressive neurodegenerative disorders by enabling the detection, preventative treatment, and tracking of disease in a paradigm shift from today's approaches that have to see the overt symptoms of disease before treating it.

  • Clinical and Medical Case Reports
  • Innovations in Clinical Trials and Research
  • Early detection or screening trials
  • Patient safety and Outcomes
  • Healthy Brain Aging Study
  • CNS drug discovery and development
  • Methodological aspects
  • Fluid-based proteomic biomarkers
  • Functional biomarkers
  • Standardization of biomarkers
  • Automated analysis techniques
  • Standardized data collection and processing

Related Conference of CNS Biomarkers: Drug Discovery, Research and Development

November 19-20, 2018

29th World Cardiology Conference

Edinburgh, Scotland
November 21-22, 2018

International Conference on Cardiovascular Diseases and Therapeutics

| Paris, France

Venue: Holiday Inn Paris - Marne la Vallée

November 21 - 22, 2018 |

6th World Congress on Hypertension and Public Health

Paris, France
February 18-19, 2019

30th European Heart Diseases and Heart Failure Congress

Amsterdam, Netherlands
Feb 28-March 01, 2019

World Cardiology Experts Meeting

Osaka, Japan
March 15-16, 2019

4th Global Summit on Heart Diseases

Holiday Inn Atrium Singapore | Singapore
March 18-20, 2019

Middle East Heart Congress

Dubai, UAE
March 27- 28, 2019

5th World Heart Congress

Sydney, Australia
April 15 -16, 2019

5th World Heart Congress

Amsterdam, Netherlands
April 17-18, 2019

World Congress on Cardiac Surgery & Medical Devices 2019

Montreal | Quebec | Canada
April 19-20, 2019

World Heart and Brain Congress

Chicago, USA
April 29 - May 01, 2019

4th World Heart Congress

ANA Crowne Plaza Kyoto | Kyoto, Japan

World Cardiology and Cardiologist Meet

August 5-6, 2019 Cannes, France
May 13-14, 2019

2nd Global Cardiology Summit

Perth, Australia
June 17-19, 2019

31st Annual Cardiologists Conference

Rome, Italy
July 01-02, 2019

European Cardiology Congress

Prague | Czech Republic
July 10-11, 2019

25th World Cardiology Conference

Osaka, Japan
July 10-11,2019

26th Annual Cardiologists Conference

Osaka,Japan
July 26-27, 2019

4th International Conference on Hypertension and Healthcare

Mercure Albert Park | Melbourne, Australia
July 31-August 01, 2019

27th International Congress on Cardiology and medical interventions

Chicago, Illinois, USA
August 19- 20, 2019

7th World Heart Congress

Vienna, Austria
September 25-26, 2019

2nd World Heart and Brain Conference

Helsinki, Finland
October 23-24, 2019

European Heart Congress

Prague | Czech Republic
October 24-26, 2019

32nd European Cardiology Conference

Zurich, Switzerland

CNS Biomarkers: Drug Discovery, Research and Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in